Founded in 2008, Viva Biotech provides a range of services including target protein expression and structure research, hit screening, lead optimization, and drug candidate determination. They have served over 370 biotechnology and pharmaceutical customers, delivering 9,500 independent protein strains and assisting with over 1,000 drug targets. Through their Viva BioInnovator program, they identify early-stage biotech startups for incubation, equity-for-service, and investment opportunities. Viva Biotech is listed as Viva Biotech (Hk: 01873) and is focused on biomedical technology and biological products research and development.